Delivery Order SPE2DB20D3303-SPE2DB25FA3NH
Award Date 9/10/25
Potential Completion Date 9/11/25
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $111,754.45 to AmerisourceBergen Drug Corp for the supply of REXULTI 2 mg tablets (30-count units) under a firm fixed price arrangement. The award, issued on July 21, 2025, with completion scheduled for July 22, 2025, represents a non-competitive delivery against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. Performance will...
- The Defense Logistics Agency awarded a delivery order valued at $6,945.34 to AmerisourceBergen Drug Corp for REXULTI 2 mg tablets (30-count packages) on September 2, 2025, with completion scheduled for September 3, 2025. This non-set-aside, firm fixed-price contract represents a routine pharmaceutical procurement supporting federal medical supply chain operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $13,652.36, is for the delivery of REXULTI 4 MG TABLET 30S, a pharmaceutical product, with a period of performance through April 15, 2024. This delivery order is part of a larger indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,914.33 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, with a completion date of January 4, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, provides a range of pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,259.26 for REXULTI 0.5 mg tablets (30-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price, competitively awarded contract (no set-aside designation) leverages AmerisourceBergen's position as a prime vendor under the DLA Troop Support Medical Indefinite Delivery Contract SPE2DX, valued at $999,999,999.00 through December 2026. The pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 7, 2025, for REXULTI 3 MG tablets (30-count supply) with a ceiling value of $22,083.84. This firm fixed price delivery order represents a non-competitive set-aside contract and is scheduled for ultimate completion by August 8, 2025. The award is executed under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,563,969,451 REXULTI 0.5 mg tablets in quantities of 30. The $3,448.07 award has an ultimate completion date of March 15, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which serves as the primary vehicle for...
- The Defense Logistics Agency awarded a $4,102.92 delivery order to AmerisourceBergen Drug Corp for 30 tablets of REXULTI 3 mg on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed price contract is a non-set-aside award issued under a competitive procurement process. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters location. This delivery order is issued as a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies on August 1, 2025, with an ultimate completion date of August 4, 2025. The order, valued at $3,251.51, covers REXULTI 2 mg tablets in a 30-count package. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,866.33 Firm Fixed Price Delivery Order contract has an ultimate completion date of December 11, 2024 and provides the REXULTI 4 MG TABLET 30S pharmaceutical product. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through...